Johnson & Johnson profit grows on strength in pharma business

Note: This section contains information in English only.
Source: Dukascopy Bank SA
Johnson & Johnson reported a higher-than-expected quarterly revenue and profit, as strong demand for cancer drugs made up for decreasing sales of other treatments.

Actual Topics